Related Experiment Videos

RNF213-TRAF2 interaction enhances inflammatory responses via NF-κB activation in moyamoya disease

Mitsutaka Yasuda1,2, Kaoru Murakami1, Jing-Jing Jiang1,3

  • 1Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo 060-0815, Japan.

Insights

RNF213 regulates inflammation in Moyamoya disease (MMD) by controlling the IL-6 amplifier. The MMD-associated RNF213 variant enhances this pathway, contributing to disease pathogenesis and suggesting new therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Moyamoya disease (MMD) is a cerebrovascular disorder with unknown molecular mechanisms, though inflammation is implicated.
  • RNF213 is a key MMD susceptibility gene, but its role in NF-κB inflammation is unclear.

Purpose of the Study:

  • To investigate the role of RNF213 in NF-κB-driven inflammation and its contribution to MMD pathogenesis.
  • To elucidate the function of the MMD-associated RNF213 p.R4810K variant in inflammatory signaling.

Main Methods:

  • Utilized cell culture models (H4 cells, arachnoid cells) to study IL-6 amplifier (IL6-Amp) induction and NF-κB signaling.
  • Employed in vivo models (imiquimod-induced ear swelling) to assess RNF213's role in inflammation.
  • Analyzed patient-derived superficial temporal artery tissues for genotype-dependent inflammatory markers.

Main Results:

  • RNF213 knockdown reduced IL-6 expression and NF-κB target genes in vitro.
  • RNF213 depletion attenuated inflammation in vivo.
  • The MMD-associated RNF213 p.R4810K variant enhanced NF-κB activation by strengthening RNF213-TRAF2 interaction.
  • MMD patient arteries showed genotype-dependent IL6-Amp activation, with increased NF-κB p65 and STAT3 phosphorylation in homozygous carriers.

Conclusions:

  • RNF213 is a critical regulator of NF-κB-driven inflammation via the IL6-Amp.
  • The MMD-associated RNF213 variant amplifies inflammatory signaling, contributing to MMD pathogenesis.
  • This study identifies potential therapeutic targets for MMD by focusing on inflammation modulation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
18.6K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K